Impact of fingolimod on CD4+ T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients.
Kürtüncü M, Yılmaz V, Akçay Hİ, Türkoğlu R, Altunrende B, Çınar SA, Ulusoy C, Gündüz T, İçöz S, Kasap M, Çalışkan Z, Ötünç G, Eraksoy M, Tüzün E.
Kürtüncü M, et al. Among authors: caliskan z.
J Neuroimmunol. 2019 Dec 15;337:577065. doi: 10.1016/j.jneuroim.2019.577065. Epub 2019 Sep 11.
J Neuroimmunol. 2019.
PMID: 31526917
Clinical Trial.